5-Cyclobutyl-4H-1,2,4-triazol-3-ylamine, 95.0%, 10g

2,2'-Cyclopropylidenebis(4,4,5,5-tetramethyl-1,3,2-dioxaborolane)>98.0%(GC)1g

ethyl 5-(chlorosulfonyl)-3-methyl-1H-pyrazole-4-carboxylate, 95.0%, 250mg

N-Succinimidyl 3-Maleimidopropionate [Cross-linking Reagent]>98.0%(HPLC)(N)5g

3,5-Dichloro-4-methoxyphenylboronic acid, 95.0%, 5g

3-Bromo-1-naphthoic acid, 95.0%, 1g

(S)-3-(3-CHLOROPHENYL)-BETA-ALANINOL HCL, 97.0%, 1g

3-OXO-1,3-DIHYDRO-2-BENZOFURAN-5-CARBOXYLIC ACID, 95.0%, 100mg

S-Methylisothiourea Sulfate>98.0%(T)100g

4-(1-piperidinyl)pentanoic acid hydrochloride, 95.0%, 100mg

(4-Chloropyrimidin-5-yl)methanol, 98%, 5g

GC capillary column ROTI®Cap-1701, 30 m, 0.32 mm, 0.35 µm, 1 Piece(s)

tert-Butyl (R)-(4,4-difluoropiperidin-3-yl)carbamate, 98%, 100mg